The ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) initial kick-off took place on 2 March 2021 as a virtual meeting. The ECRAID-Base project follows the successful ECRAID-Plan project which defined the business model of the ECRAID network. This pan-European network will generate rigorous evidence to improve diagnosis, prevention and treatment of infections and to better respond to emerging infectious disease threats.
Through the ECRAID-Base project, the foundations of this network will be cemented and develop into a self-sustaining, not for profit organisation working with both the public and private sponsors on clinical research.
This project will support six perpetual observational studies (POS) across Europe. Five of these studies will be new studies carried out in ICU, ER and primary care settings in different infectious disease areas. They will all have the possibility of integrating clinical trials and developing into adaptive platform trials. The ECRAID Base project will also support the ongoing international adaptive platform trial REMAP-CAP. The network will be supported by crosscutting efforts on laboratory management, data management and training, ensuring efficient network management and continuous capacity building. ECRIN will contribute to the development and the operations of the data infrastructure for ECRAID, and will support the implementation of the POS and subsequent clinical trials.
The ECRAID-Base project is funded by Horizon 2020 through the Grant Agreement n° 965313.